Literature DB >> 29220598

Hope for the Future But Fear the Risk of Stigma: Ethiopian Family Caregivers' Lived Experience of Caring for Their HIV Positive Child Two Years After Starting Antiretroviral Treatment.

Mulatu Biru1, Pia Lunqvist1, Mitikie Molla2, Degu Jerene3, Inger Hallström1.   

Abstract

Family caregivers are believed to be the primary source of support for HIV-affected children. There is limited evidence about practices of support for caregivers, to strengthen them and to enhance the welfare of HIV positive children, especially in African settings. Our aim was therefore to illuminate caregivers' lived experiences of caring for a child in Ethiopia 2 years after the child was enrolled in antiretroviral therapy. Qualitative interviews with 18 family caregivers of 18 children were performed and analyzed using an inductive design with a hermeneutic phenomenological approach. The family caregivers' lived experience was shown in two main themes comprising "lifelong medication gives hope for the future" and "support challenged by the fear of stigma." The family caregivers experienced hope and dreams for the future as they saw their child as healthy and they had regained normality in life after the child's diagnosis. The caregivers still feared the disclosure of the child's diagnosis, which gave rise to conflicts with the child, the family, and society. Good quality support from the healthcare staff lightened their burdens. Further studies are recommended on the strategies of stigma reduction and developing need-specific modalities to support caregivers in the community.

Entities:  

Keywords:  Antiretroviral treatment; caregivers; child; hope; risk of stigma

Mesh:

Year:  2017        PMID: 29220598     DOI: 10.1080/24694193.2017.1372531

Source DB:  PubMed          Journal:  Compr Child Adolesc Nurs


  1 in total

1.  Adolescents living with HIV are at higher risk of death and loss to follow up from care: Analysis of cohort data from eight health facilities in Ethiopia.

Authors:  Degu Jerene; Workeabeba Abebe; Kefyalew Taye; Andrea Ruff; Inger Hallstrom
Journal:  PLoS One       Date:  2019-10-17       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.